Association of serum uric acid levels in psoriasis: A systematic review and meta-analysis

Medicine (United States)

Volumn 95, Issue 19, 2016, Pages

  Li, Xin ^a,b   Miao, Xiao ^a   Wang, Hongshen ^b   Wang, Yifei ^a   Li, Fulun ^a   Yang, Qiong ^c   Cui, Rutao ^b   Li, Bin ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

EAST ASIAN; HUMAN; HYPERURICEMIA; INDIA; ITALY; MIDDLE EAST; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RACE DIFFERENCE; REVIEW; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL; WESTERN EUROPE; ADULT; AGED; BLOOD; COMPLICATION; EUROPE; FAR EAST; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; OBSERVATIONAL STUDY;

ADULT; AGED; EUROPE; FAR EAST; FEMALE; HUMANS; HYPERURICEMIA; INDIA; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PSORIASIS; URIC ACID;

EID: 84970046150     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003676     Document Type: Review

References (42)

1. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. 2009;60:218-224.
2. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes Immun. 2007;8:1-12.
3. Wolf N, Quaranta M, Prescott NJ, et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet. 2008;45:114-116.
4. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829-835.
5. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68:654-662.
6. Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom. J invest Dermatol. 2012;132(3 Pt 1):556-562.
7. Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: A population-based study. Br J Dermatol. 2011;165:1037-1043.
8. Zindanci I, Albayrak O, Kavala M, et al. Prevalence of metabolic syndrome in patients with psoriasis. Sci World J. 2012;2012:312463.
9. Johnson RJ, Segal MS, Sautin Y, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86:899-906.
10. Johnson RJ, Titte S, Cade JR, et al. Uric acid, evolution and primitive cultures. Sem Nephrol. 2005;25:3-8.
11. Kleber ME, Delgado G, Grammer TB, et al. Uric acid and cardiovascular events: A Mendelian randomization study. J Am Soc Nephrol. 2015;26:2831-2838.
12. Lea WA Jr, Curtis AC, Bernstein IA. Serum uric acid levels in psoriasis. J Investig Dermatol. 1958;31:269-271.
13. Baumann RR, Jilison OF. Hyperuricemia and psoriasis. J Investig Dermatol. 1961;36:105-107.
14. Eisen AZ, Seegmiller JE. Uric acid metabolism in psoriasis. J Clin Investig. 1961;40:1486-1494.
15. Scott JT, Stodell MA. Serum uric acid levels in psoriasis. Adv Exp Med Biol. 1984;165(Pt A):283-285.
16. Rajappa M, Rathika S, Munisamy M, et al. Effect of treatment with methotrexate and coal tar on adipokine levels and indices of insulin resistance and sensitivity in patients with psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2015;29:69-76.
17. Houshang N, Reza K, Masoud S, et al. Antioxidant status in patients with psoriasis. Cell Biochem Funct. 2014;32:268-273.
18. Gisondi P, Targher G, Cagalli A, et al. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2014;70:127-130.
19. Ataseven A, Kesli R, Kurtipek GS, et al. Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis. Dis Markers. 2014;2014:541709.
20. Alpsoy S, Akyuz A, Erfan G, et al. Atherosclerosis, some serum inflammatory markers in psoriasis. Giornale Ital Dermatol Venereol. 2014;149:167-175.
21. Zhou Z, Chen J, Zhou R, et al. The study of characteristics of hematological and biochemical parameters in patients with psoriasis and their values in its diagnosis and treatment. Int J Lab Med. 2013;34:1679-1681.
22. Zhang D, Luo W, Wang J, et al. The level of detection and significance of serum uric acid in patients with psoriasis. J Practical Dermatol. 2012;5:132-134.
23. Ibrahim SE, Helmi A, Yousef TM, et al. Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis. Egypt Rheumatol. 2012;34:83-89.
24. Kwon HH, Kwon IH, Choi JW, et al. Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis. Clin Exp Dermatol. 2011;36:473-478.
25. Isha, Jain VK, Lal H. C-reactive protein and uric acid levels in patients with psoriasis Indian J Clin Biochem. 2011;26:309-311.
26. Cassano N, Carbonara M, Panaro M, et al. Role of serum uric acid in conditioning the association of psoriasis with metabolic syndrome. Eur J Dermatol. 2011;21:808-809.
27. Feng W, Wang L, Jin S, et al. Measurement and analysis of serum uric acid levels in patients with psoriasis. Chin J Dermatol. 2003;36:167.
28. Severin E, Nave B, Stander M, et al. Total antioxidative capacity is normal in sera from psoriasis patients despite elevated bilirubin, tocopherol and urate levels. Dermatology. 1999;198:336-339.
29. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-605.
30. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Metaanalysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
31. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34:J314-321.
32. Enamandram M, Kimball AB. Psoriasis epidemiology: The interplay of genes and the environment. J Investig Dermatol. 2013;133:287-289.
33. Mood C. Life-style and self-rated global health in Sweden: A prospective analysis spanning three decades. Prev Med. 2013;57:802-806.
34. Merola JF, Wu S, Han J, et al. Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheumatic Dis. 2015;74:1495-1500.
35. Jin YL, Zhu T, Xu L, et al. Uric acid levels, even in the normal range, are associated with increased cardiovascular risk: The Guangzhou Biobank Cohort Study. Int J Cardiol. 2013;168:2238-2241.
36. Ioachimescu AG, Brennan DM, Hoar BM, et al. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008;58:623-630.
37. Mazza A, Zamboni S, Rizzato E, et al. Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL). Acta Diabetol. 2007;44:99-105.
38. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med. 2004;164: 1546-1551.
39. Osgood K, Krakoff J, Thearle M. Serum uric acid predicts both current and future components of the metabolic syndrome. Metab Syndr Relat Disorders. 2013;11:157-162.
40. Zhang Q, Zhang C, Song X, et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health. 2012;12:419.
41. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007;120:442-447.
42. Kristensen SL, McInnes IB, Sattar N. Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Ann Rheum Dis. 2015;74:321-322.